![](/img/cover-not-exists.png)
EPA-0682 – Investigator-rated symptomatological outcomes in a phase 4 study of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder and impaired executive function
Adler, L., Raychaudhuri, A., Dirks, B.Volume:
29
Year:
2014
Language:
english
Journal:
European Psychiatry
DOI:
10.1016/S0924-9338(14)78049-6
File:
PDF, 77 KB
english, 2014